Top compounds associated with response to MYT1


Feature Type Standardized
Nominal ANOVA
mRNA paclitaxel UHNBreast pan-cancer AAC -0.39 0.2
mRNA lapatinib UHNBreast pan-cancer AAC -0.38 0.2
mRNA Bicalutamide FIMM pan-cancer AAC -0.25 0.1
mRNA PD-0325901 gCSI pan-cancer AAC -0.25 7e-07
mRNA Erlotinib gCSI pan-cancer AAC -0.23 3e-05
mRNA Sunitinib FIMM pan-cancer AAC -0.23 0.2
mRNA S-Trityl-L-cysteine FIMM pan-cancer AAC -0.22 0.2
mRNA Dasatinib FIMM pan-cancer AAC -0.22 0.2
mRNA bid1870 gCSI pan-cancer AAC -0.22 7e-05
mRNA lenalidomide FIMM pan-cancer AAC -0.21 0.2
Download CSV